hyperactivity hyperkinetic syndrome
Conditions
Interventions
None listed
Sponsors
Shire
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: Patients meeting all of the criteria listed below at the time of consent may be included in the study: 1. Documented diagnosis of ADHD by a physician/clinician. 2. Age 18 years or older. 3. Read, comprehend, and speak the native language of the country in which they reside. 4. An understanding, ability, and willingness to participate in the study and comply with the requirements of the protocol. 5. Ability to provide written, signed, and dated (personally) informed consent to participate in the study.
Exclusion criteria
Exclusion criteria: Patients are excluded from the study if any of the following criteria are met at screening/enrollment: 1. Life expectancy less than 12 months. 2. Currently enrolled in an ADHD clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Multiple study questions, rather than hypotheses, will be addressed over the course of the study. | — |
Secondary
| Measure | Time frame |
|---|---|
| Multiple study questions, rather than hypotheses, will be addressed over the course of the study. | — |
Countries
Netherlands
Outcome results
None listed